Hengrui Pharma Repurchases 10,000 A Shares for ESOP, Outstanding Float Falls 0.0002%

Bulletin Express

Jun 10

Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma; HKEX: 01276) disclosed on 10 June 2026 that it bought back 10,000 A shares on the Shanghai Stock Exchange for its A-share Employee Stock Ownership Schemes (ESOP).

The repurchase was executed on 10 June 2026 at prices between RMB 46.02 and RMB 46.06 per share, translating into a volume-weighted average cost of RMB 46.04 and a total consideration of RMB 0.46 million.

Following the transaction: • Issued shares in public hands (excluding treasury shares) declined from 6,370.97 million to 6,370.96 million, a reduction of 0.0002%. • Treasury shares rose from 8.03 million to 8.04 million. • Total issued share capital remained unchanged at 6,379.00 million shares, as the repurchased stock is held in treasury and not yet cancelled.

The company confirmed that the repurchase was duly authorised, executed in compliance with all applicable regulations and stock-exchange rules, and that full payment for the shares has been settled.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1143399343"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1143399343\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1143399343?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-10 17:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1143399343","market":"hk","top_or_hot":-1,"title":"Hengrui Pharma Repurchases 10,000 A Shares for ESOP, Outstanding Float Falls 0.0002%","media":"Bulletin Express","content":"<p>Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma; HKEX: 01276) disclosed on 10 June 2026 that it bought back 10,000 A shares on the Shanghai Stock Exchange for its A-share Employee Stock Ownership Schemes (ESOP).</p>\n<p>The repurchase was executed on 10 June 2026 at prices between RMB 46.02 and RMB 46.06 per share, translating into a volume-weighted average cost of RMB 46.04 and a total consideration of RMB 0.46 million.</p>\n<p>Following the transaction:\n• Issued shares in public hands (excluding treasury shares) declined from 6,370.97 million to 6,370.96 million, a reduction of 0.0002%.  \n• Treasury shares rose from 8.03 million to 8.04 million.  \n• Total issued share capital remained unchanged at 6,379.00 million shares, as the repurchased stock is held in treasury and not yet cancelled.</p>\n<p>The company confirmed that the repurchase was duly authorised, executed in compliance with all applicable regulations and stock-exchange rules, and that full payment for the shares has been settled.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hengrui Pharma Repurchases 10,000 A Shares for ESOP, Outstanding Float Falls 0.0002%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHengrui Pharma Repurchases 10,000 A Shares for ESOP, Outstanding Float Falls 0.0002%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-10 17:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma; HKEX: 01276) disclosed on 10 June 2026 that it bought back 10,000 A shares on the Shanghai Stock Exchange for its A-share Employee Stock Ownership Schemes (ESOP).</p>\n<p>The repurchase was executed on 10 June 2026 at prices between RMB 46.02 and RMB 46.06 per share, translating into a volume-weighted average cost of RMB 46.04 and a total consideration of RMB 0.46 million.</p>\n<p>Following the transaction:\n• Issued shares in public hands (excluding treasury shares) declined from 6,370.97 million to 6,370.96 million, a reduction of 0.0002%.  \n• Treasury shares rose from 8.03 million to 8.04 million.  \n• Total issued share capital remained unchanged at 6,379.00 million shares, as the repurchased stock is held in treasury and not yet cancelled.</p>\n<p>The company confirmed that the repurchase was duly authorised, executed in compliance with all applicable regulations and stock-exchange rules, and that full payment for the shares has been settled.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01276","symbol_name":"恒瑞医药","start_time":0,"source_url":"","article_id":"1143399343","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1143399343","pubTimestamp":1781084569,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma; HKEX: 01276) disclosed on 10 June 2026 that it bought back 10,000 A shares on the Shanghai Stock Exchange for its A-share Employee Stock...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01276":"恒瑞医药"},"translate_title":"恒瑞医药回购1万股A股用于ESOP流通股跌0.0002%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01276":1},"content_text":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma; HKEX: 01276) disclosed on 10 June 2026 that it bought back 10,000 A shares on the Shanghai Stock Exchange for its A-share Employee Stock Ownership Schemes (ESOP).\nThe repurchase was executed on 10 June 2026 at prices between RMB 46.02 and RMB 46.06 per share, translating into a volume-weighted average cost of RMB 46.04 and a total consideration of RMB 0.46 million.\nFollowing the transaction:\n• Issued shares in public hands (excluding treasury shares) declined from 6,370.97 million to 6,370.96 million, a reduction of 0.0002%.  \n• Treasury shares rose from 8.03 million to 8.04 million.  \n• Total issued share capital remained unchanged at 6,379.00 million shares, as the repurchased stock is held in treasury and not yet cancelled.\nThe company confirmed that the repurchase was duly authorised, executed in compliance with all applicable regulations and stock-exchange rules, and that full payment for the shares has been settled.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}